Tumor Evolution Selectively Inactivates the Core microRNA Machinery for Immune Evasion

Investigators found that the core microRNA biogenesis and targeting machinery maintained the sensitivity of cancer cells to PD-1-independent T cell-mediated cytotoxicity.